Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/SAR stock hub

AIM/SAR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/SARis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

27.6M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/SAR

In the news

Latest news · AIM/SAR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-178.5

P25 -54.2P50 2.1P75 13.7

ROIC-87.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/SAR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

151

Groups with data

Currency

GBP

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	5
Employees Change	0%
Employees Change Percent	0
Enterprise value	GBX 25.1M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BMC3RJ87
Last refreshed	2026-05-10
Market cap	GBX 27.6M
Price	GBX 20
Price currency	GBX
Sector	Healthcare
Sic	2834
Symbol	aim/SAR
Website	https://www.sareum.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-17.85%
EV Earnings	-5.1x
P/B ratio	23.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	GBX -4.9M
Net Income Growth Years	0%
Profit Per Employee	GBX -985,800
ROA	-60.71
Roa5y	-67.42
ROCE	-322.9
ROE	-178.5
Roe5y	-130.8
ROIC	-87.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.7%
Cagr15y	-9.74%
Cagr1y	17.66%
Cagr20y	-6.4%
Cagr3y	-48.02%
Cagr5y	-29.21%
EPS Growth Quarters	1
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	GBX 3.2M
Cash	GBX 2.5M
Current Assets	GBX 3.2M
Current Liabilities	GBX 2M
Equity	GBX 1.2M
Liabilities	GBX 2M
Long Term Assets	GBX 0
Long Term Liabilities	GBX 0
Net Cash	GBX 2.5M
Net Cash By Market Cap	GBX 9.01
Net Cash Growth	-39.98%
Net Debt Equity	GBX -2.08
Tangible Book Value	GBX 1.2M
Tangible Book Value Per Share	GBX 0.01
WACC	-0.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.59
Net Working Capital	GBX -1.3M
Quick ratio	1.59
Working Capital	GBX 1.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-19.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-50%
1Y total return	17.65%
200-day SMA	17.88
3Y total return	-85.96%
50-day SMA	17.31
50-day SMA vs 200-day SMA	50under200
5Y total return	-82.22%
All Time High	500
All Time High Change	-96%
All Time High Date	2021-08-06
All Time Low	1.5
All Time Low Change	1,233.33%
All Time Low Date	2009-01-16
ATR	1.53
Beta	-0.81
Beta1y	1.19
Beta2y	0.3
Ch YTD	33.33
High	21
High52	29
High52 Date	2025-09-18
High52ch	-31.03%
Low	19.84
Low52	9.5
Low52 Date	2025-10-10
Low52ch	110.53%
Ma50ch	15.54%
Price vs 200-day SMA	11.88%
RSI	59.47
RSI Monthly	42.93
RSI Weekly	57.47
Sharpe ratio	0.5x
Sortino ratio	0.92
Total Return	-19.28%
Tr YTD	33.33
Tr15y	-78.49%
Tr1m	25%
Tr1w	-1.23%
Tr3m	17.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -3.9M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	132,613,866%
Shares Insiders	2.27%
Shares Institutions	82.05%
Shares Out	138,065,173
Shares Qo Q	14.16%
Shares Yo Y	19.28%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	203,736.45x
Bv Per Share	0.01
Ch10y	-50
Ch15y	-78.49
Ch1m	25
Ch1w	-1.23
Ch1y	17.65
Ch20y	-73.33
Ch3m	17.65
Ch3y	-85.96
Ch5y	-82.22
Ch6m	37.93
Change	0%
Change From Open	-1.91
Close	20
Days Gap	1.95
Dollar Volume	631,340
Earnings Date	2026-06-10
EBIT	GBX -3.9M
EPS	GBX -0.04
F Score	1
Financing CF	1,584,000
Fiscal Year End	June
Founded	2,004
Income Tax	GBX -498,000
Investing CF	100,000
Is Primary Listing	1
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Last Split Date	2022-03-01
Last Split Type	Reverse
Ma150	16.5
Ma150ch	21.19%
Ma20	20.2
Ma20ch	-0.99%
Net CF	-1,657,000
Next Earnings Date	2026-06-10
Open	20.39
Position In Range	13.79
Price Date	2026-05-08
Ptbv Ratio	23.13
Relative Volume	0.15x
Tr20y	-73.33%
Tr6m	37.93%
Volume	31,567

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/SAR pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/SAR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/SAR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+82.0%

Share of float held by funds and institutions

Insider ownership

+2.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+19.3%

Negative means the company is buying back shares.

Technical

AIM/SAR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.5

Neutral momentum band

Price vs 200-day MA

+11.9%

50/200-day relationship not available

Beta (5Y)

-0.81

Less volatile than the market

Sharpe ratio

0.50

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/SAR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/SAR stock rating?

aim/SAR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/SAR analysis?

The full report lives at /stocks/aim/SAR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/SAR?

The latest report frames aim/SAR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/SAR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.